Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2014 | 6.19 Million USD | 225.38% |
| 2013 | 1.9 Million USD | -41.68% |
| 2012 | 3.26 Million USD | 126.71% |
| 2011 | 1.44 Million USD | -68.25% |
| 2010 | 4.53 Million USD | -28.85% |
| 2009 | 6.37 Million USD | 346.5% |
| 2008 | 1.42 Million USD | -37.76% |
| 2007 | 2.29 Million USD | -61.11% |
| 2006 | 5.9 Million USD | 107.93% |
| 2005 | 2.83 Million USD | -27.47% |
| 2004 | 3.91 Million USD | -90.07% |
| 2003 | 39.4 Million USD | 1323.86% |
| 2002 | 2.76 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2015 Q3 | 3.56 Million USD | 649.46% |
| 2015 Q1 | 1.26 Million USD | -54.98% |
| 2015 Q2 | 476.14 Thousand USD | -62.39% |
| 2014 Q1 | 708.01 Thousand USD | -35.44% |
| 2014 FY | 6.19 Million USD | 225.38% |
| 2014 Q4 | 2.81 Million USD | 380.75% |
| 2014 Q3 | 585.08 Thousand USD | -72.03% |
| 2014 Q2 | 2.09 Million USD | 195.43% |
| 2013 FY | 1.9 Million USD | -41.68% |
| 2013 Q4 | 1.09 Million USD | 285.61% |
| 2013 Q1 | 280.73 Thousand USD | -75.6% |
| 2013 Q3 | 284.38 Thousand USD | 14.54% |
| 2013 Q2 | 248.28 Thousand USD | -11.56% |
| 2012 Q4 | 1.15 Million USD | 274.92% |
| 2012 Q1 | 372.52 Thousand USD | 32.1% |
| 2012 FY | 3.26 Million USD | 126.71% |
| 2012 Q3 | 306.84 Thousand USD | -29.65% |
| 2012 Q2 | 436.18 Thousand USD | 17.09% |
| 2011 Q4 | 282 Thousand USD | -27.1% |
| 2011 FY | 1.44 Million USD | -68.25% |
| 2011 Q2 | 376.95 Thousand USD | -4.53% |
| 2011 Q3 | 386.81 Thousand USD | 2.61% |
| 2011 Q1 | 394.84 Thousand USD | -74.48% |
| 2010 Q1 | 848.54 Thousand USD | -84.13% |
| 2010 FY | 4.53 Million USD | -28.85% |
| 2010 Q4 | 1.54 Million USD | 165.44% |
| 2010 Q3 | 582.95 Thousand USD | -62.61% |
| 2010 Q2 | 1.55 Million USD | 83.72% |
| 2009 FY | 6.37 Million USD | 346.5% |
| 2009 Q2 | 340.25 Thousand USD | -2.21% |
| 2009 Q4 | 5.34 Million USD | 1461.93% |
| 2009 Q3 | 342.33 Thousand USD | 0.61% |
| 2009 Q1 | 347.93 Thousand USD | -9.0% |
| 2008 Q3 | 379.37 Thousand USD | 22.8% |
| 2008 FY | 1.42 Million USD | -37.76% |
| 2008 Q4 | 382.36 Thousand USD | 0.79% |
| 2008 Q1 | 269.2 Thousand USD | -92.83% |
| 2008 Q2 | 308.92 Thousand USD | 14.76% |
| 2007 Q1 | -764.07 Thousand USD | -127.81% |
| 2007 FY | 2.29 Million USD | -61.11% |
| 2007 Q4 | 3.75 Million USD | 1365.27% |
| 2007 Q3 | 256.18 Thousand USD | 126.94% |
| 2007 Q2 | -950.87 Thousand USD | -24.45% |
| 2006 Q2 | 817.03 Thousand USD | 26.26% |
| 2006 Q3 | -1.34 Million USD | -264.44% |
| 2006 FY | 5.9 Million USD | 107.93% |
| 2006 Q4 | 2.74 Million USD | 304.5% |
| 2006 Q1 | 647.11 Thousand USD | 252.44% |
| 2005 Q1 | 1.61 Million USD | -31.72% |
| 2005 Q4 | 183.61 Thousand USD | -71.8% |
| 2005 Q3 | 651.13 Thousand USD | 69.0% |
| 2005 FY | 2.83 Million USD | -27.47% |
| 2005 Q2 | 385.28 Thousand USD | -76.19% |
| 2004 Q1 | 482.33 Thousand USD | -98.68% |
| 2004 Q4 | 2.36 Million USD | 459.01% |
| 2004 FY | 3.91 Million USD | -90.07% |
| 2004 Q3 | 423.88 Thousand USD | -33.48% |
| 2004 Q2 | 637.26 Thousand USD | 32.12% |
| 2003 Q1 | 1.1 Million USD | 707.35% |
| 2003 Q4 | 36.42 Million USD | 3496.68% |
| 2003 Q3 | 1.01 Million USD | 17.04% |
| 2003 FY | 39.4 Million USD | 1323.86% |
| 2003 Q2 | 865.26 Thousand USD | -21.6% |
| 2002 Q4 | 136.7 Thousand USD | -93.07% |
| 2002 Q1 | 323.1 Thousand USD | 0.0% |
| 2002 Q3 | 1.97 Million USD | 0.0% |
| 2002 FY | 2.76 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -490.808% |
| Atlantic International Corp. | 5.57 Million USD | -11.102% |
| Biocept, Inc. | 29.4 Million USD | 78.921% |
| Bioqual, Inc. | 7.44 Million USD | 16.797% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -702.647% |
| DermTech, Inc. | 104.01 Million USD | 94.042% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 96.278% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 72.606% |
| iMD Companies, Inc. | 151.8 Thousand USD | -3982.483% |
| IDenta Corp. | 662.97 Thousand USD | -834.813% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 69.367% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -15839.858% |
| InVitro International | 661.32 Thousand USD | -837.147% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 12.686% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -10564.882% |
| Medical Imaging Corp. | 1.91 Million USD | -224.113% |
| NovelStem International Corp. | 3.53 Million USD | -75.182% |
| Optigenex Inc. | 1.28 Million USD | -381.227% |
| PharmChem, Inc. | 2.93 Million USD | -111.433% |
| Proteome Sciences plc | 3.26 Million USD | -89.644% |
| Response Genetics, Inc | 25.31 Million USD | 75.522% |
| Rennova Health, Inc. | 7.67 Million USD | 19.279% |
| RushNet, Inc. | 1.78 Million USD | -246.365% |
| ScreenPro Security Inc. | 3.23 Million USD | -91.347% |
| Stella Diagnostics Inc. | 11.42 Million USD | 45.764% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 15.599% |
| Todos Medical Ltd. | 14.05 Million USD | 55.914% |